Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
719 participants
INTERVENTIONAL
2017-02-13
2021-10-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* What are the Nigeria Breast Cancer Study (NBCS) and Gail models estimates of the BC risk of first-degree female relatives of BC patients in South-West, Nigeria?
* What are the effects of BC risk assessment and counseling on adherence to breast screening recommendations among first-degree female relatives of BC patients in South-West, Nigeria?
* What are the effects of BC risk assessment and counseling on adherence to lifestyle risk reduction recommendations among first-degree female relatives of BC patients in South-West, Nigeria?
* What is the knowledge, attitudes, and perception of first-degree female relatives of BC patients in South-West Nigeria towards genetic testing and BC etiology?
* What factors predict breast screening among first-degree female relatives of BC patients in South-West Nigeria?
* What factors predict the time to first BC screening (post-intervention) among first-degree female relatives of BC patients in South-West Nigeria?
Participants will be randomized into the control arm (standard care) and intervention arms of the study. The intervention arm of the study will have a BC risk assessment followed by individualized BC risk counseling. In addition, the intervention arm will receive BC awareness and MammaCare® BSE training. The control arm will receive only standard care comprising BC awareness and MammaCare® BSE training. Both study arms will receive BC screening recommendations and lifestyle modification recommendations.
We hope that the BC risk counseling will improve BC screening practices and modification of risk behaviors and this hypothesis will be tested.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Case Control Study to Identify Modifiable Risk Factors for Colorectal and Breast Cancer in Nigeria
NCT05044689
Improving Access to Breast Cancer Screening and Treatment in Nigeria: The Triple Mobile Assessment and Patient Navigation Model
NCT05321823
The Ghana Breast Health Study
NCT01661023
Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)
NCT05561842
Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria
NCT04501419
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard care (SC)
Participants received one-on-one breast cancer awareness education; one-on-one monthly Breast Self-Examination (BSE) training; general breast cancer screening recommendations; and general lifestyle modification recommendations
No interventions assigned to this group
SC + Risk assessment and counselling
Participants received Standard care as described in the SC arm above in addition to individualized breast cancer risk assessment, individualized breast cancer risk counseling, and lifestyle risk reduction recommendations
Individualized breast cancer risk assessment
Individualized breast cancer risk assessment: The Nigerian Breast Cancer Study (NBCS) absolute risk prediction model was used to predict the 5-year and lifetime breast cancer risks of the participants. The model utilized individual breast cancer risk factors.
Individualized breast cancer risk counselling
Individualized breast cancer risk counselling: The Principal Investigator (PI) and other trained risk counsellors discussed the results of the NBCS risk prediction model with participants and counselled them about the risk of developing breast cancer. The
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Individualized breast cancer risk assessment
Individualized breast cancer risk assessment: The Nigerian Breast Cancer Study (NBCS) absolute risk prediction model was used to predict the 5-year and lifetime breast cancer risks of the participants. The model utilized individual breast cancer risk factors.
Individualized breast cancer risk counselling
Individualized breast cancer risk counselling: The Principal Investigator (PI) and other trained risk counsellors discussed the results of the NBCS risk prediction model with participants and counselled them about the risk of developing breast cancer. The
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Women aged 20 to 75 years of age
3. Willingness to be contacted after six months for follow-up
Exclusion Criteria
2. Previous exposure to breast cancer risk assessment and counselling
3. Absence of intact breasts
20 Years
75 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lagos State University Teaching Hospital (LASUTH)
UNKNOWN
Obafemi Awolowo University Teaching Hospital
OTHER
Lagos University Teaching Hospital (LUTH)
UNKNOWN
University College Hospital, Ibadan
OTHER
University of Ibadan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Agwai Celia Imaria
Epidemiologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
OLADOSUN A OJENGBEDE, FMCOG, FWACS, FICS, M.B.B.S
Role: PRINCIPAL_INVESTIGATOR
CENTER FOR POPULATION AND REPRODUCTIVE HEALTH (CPRH), UNIVERSITY COLLEGE HOSPITAL, IBADAN
OLADELE O.O KALE, B.A, M.B, B.Ch, B.A.O
Role: PRINCIPAL_INVESTIGATOR
University of Ibadan
IKEOLUWAPO O. AJAYI, MBBS; PhD
Role: PRINCIPAL_INVESTIGATOR
University of Ibadan
CELIA IMARIA AGWAI, M.P.H; Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Ibadan
DEZHENG HUO, PhD
Role: STUDY_DIRECTOR
University of Chicago
OLUFUNMILAYO OLOPADE, M.D., F.A.C.P
Role: STUDY_CHAIR
University of Chicago
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Obafemi Awolowo University Teaching Hospital Complex (OAUTHC)
Ile-Ife, Osun State, Nigeria
University College Hospital (UCH)
Ibadan, Oyo State, Nigeria
Lagos State University Teaching Hospital (LASUTH)
Lagos, , Nigeria
Lagos University Teaching Hospital (LUTH)
Lagos, , Nigeria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NHREC/05/01/2008a
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.